Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
Am J Physiol Regul Integr Comp Physiol ; 317(3): R386-R396, 2019 09 01.
Article in English | MEDLINE | ID: mdl-31241978

ABSTRACT

In heart failure (HF), increases in renal sympathetic nerve activity (RSNA), renal norepinephrine spillover, and renin release cause renal vasoconstriction, which may contribute to the cardiorenal syndrome. To increase our understanding of the mechanisms causing renal vasoconstriction in HF, we investigated the interactions between the increased activity of the renal nerves and the renal release of norepinephrine and renin in an ovine pacing-induced model of HF compared with healthy sheep. In addition, we determined the level of renal angiotensin type-1 receptors and the renal vascular responsiveness to stimulation of the renal nerves and α1-adrenoceptors. In conscious sheep with mild HF (ejection fraction 35%-40%), renal blood flow (276 ± 13 to 185 ± 18 mL/min) and renal vascular conductance (3.8 ± 0.2 to 3.1 ± 0.2 mL·min-1·mmHg-1) were decreased compared with healthy sheep. There were increases in the burst frequency of RSNA (27%), renal norepinephrine spillover (377%), and plasma renin activity (141%), whereas the density of renal medullary angiotensin type-1 receptors decreased. In anesthetized sheep with HF, the renal vasoconstrictor responses to electrical stimulation of the renal nerves or to phenylephrine were attenuated. Irbesartan improved the responses to nerve stimulation, but not to phenylephrine, in HF and reduced the responses in normal sheep. In summary, in HF, the increases in renal norepinephrine spillover and plasma renin activity are augmented compared with the increase in RSNA. The vasoconstrictor effect of the increased renal norepinephrine and angiotensin II is offset by reduced levels of renal angiotensin type-1 receptors and reduced renal vasoconstrictor responsiveness to α1-adrenoceptor stimulation.


Subject(s)
Heart Failure/complications , Kidney/blood supply , Norepinephrine/metabolism , Renin/metabolism , Adrenergic alpha-1 Receptor Agonists/pharmacology , Angiotensin II Type 1 Receptor Blockers/pharmacology , Animals , Blood Pressure/physiology , Cardiac Pacing, Artificial , Female , Heart/innervation , Heart Failure/etiology , Heart Rate/physiology , Hemodynamics , Irbesartan/pharmacology , Kidney/innervation , Kidney/metabolism , Norepinephrine/pharmacology , Phenylephrine/pharmacology , Receptor, Angiotensin, Type 1/physiology , Renin/blood , Sheep , Vasoconstriction , Vasoconstrictor Agents/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL